Teva Pharmaceutical Industries LimitedTEVANYSE
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank90
5Y CAGR+4.3%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
+4.3%/yr
Long-term compound
Percentile
P90
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.24% |
| Q3 2025 | -0.69% |
| Q2 2025 | 4.47% |
| Q1 2025 | -2.32% |
| Q4 2024 | -5.82% |
| Q3 2024 | 1.02% |
| Q2 2024 | -3.35% |
| Q1 2024 | -1.62% |
| Q4 2023 | 3.30% |
| Q3 2023 | -2.34% |
| Q2 2023 | -0.83% |
| Q1 2023 | -1.26% |
| Q4 2022 | -0.54% |
| Q3 2022 | -3.66% |
| Q2 2022 | -2.39% |
| Q1 2022 | -1.27% |
| Q4 2021 | -0.39% |
| Q3 2021 | -2.73% |
| Q2 2021 | 0.39% |
| Q1 2021 | -3.23% |
| Q4 2020 | 1.82% |
| Q3 2020 | -9.55% |
| Q2 2020 | -0.61% |
| Q1 2020 | -3.72% |
| Q4 2019 | 0.39% |
| Q3 2019 | -3.67% |
| Q2 2019 | -0.72% |
| Q1 2019 | -1.37% |
| Q4 2018 | -6.73% |
| Q3 2018 | -2.94% |
| Q2 2018 | -3.11% |
| Q1 2018 | -2.03% |
| Q4 2017 | -17.97% |
| Q3 2017 | -0.32% |
| Q2 2017 | -5.39% |
| Q1 2017 | -1.74% |
| Q4 2016 | -5.93% |
| Q3 2016 | 70.49% |
| Q2 2016 | 5.07% |
| Q1 2016 | 1.60% |